regeneron receives $450 million federal contract for covid-19 antibody drug
Published 4 years ago • 2.7K plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
2:17
regeneron's antibody drug offers strong protection against covid-19
-
5:32
regeneron's science chief on starting clinical trials for covid-19 antibody drug
-
1:22
regeneron reports positive results on initial data for covid-19 antibody drug
-
4:45
regeneron ceo on teaming up with roche to develop covid-19 antibody cocktail
-
4:29
why regeneron's antibody drug will be in short supply
-
1:29
hyundai targets 30% sales rise by 2030, doubles hybrid lineup | reuters
-
5:00
novo nordisk ceo defends high price off ozempic and wegovy
-
5:38
how gov could use rfid chips when millions of americans inject covid-19 vaccine
-
2:32
regeneron covid-19 'antibody cocktail' drug enters late-stage trials
-
2:01
regeneron's antibody drug reduces risk of death in some covid patients
-
2:55
regeneron ceo on distribution of covid-19 antibody cocktail
-
6:23
regeneron ceo on fda request for expanded eua of covid antibody drug
-
2:02
regeneron's antibody drug likely to be in short supply because it's grown in live cells
-
4:17
regeneron reports antibody drug lowers risk of medical visits by 57%
-
3:53
regeneron president on covid antibody cocktail efficacy and supply chain
-
3:19
regeneron aims for covid-19 drug trials by early summer
-
1:32
president donald trump has received regeneron antibody cocktail after covid-19 diagnosis
-
3:11
regeneron chief scientist explains promising results for covid-19 antibody cocktail
-
2:23
regeneron: single dose of covid antibody cocktail provides long-term protection
-
3:55
regeneron is much greater than this covid-19 story: analyst
-
1:26
regeneron to ask fda to expand eua for antibody treatment after positive study results
-
1:59
significance of regeneron antibody cocktail: former fda chief scott gottlieb